Area of research
Cancer Research · Molecular Biology
Research interest
Research interests include RNA modifications and cancer, Cancer-related molecular mechanisms research, Cancer, Hypoxia, and Metabolism, and Cancer Research and Treatments.
Tumor-immune-neural circuit disrupts energy homeostasis in cancer cachexia
Cancer cachexia: A tumor-driven disorder of whole-body homeostasis.
Why immunotherapy fails in immune-cold tumors: A systems framework from immune baseline to designable immune remodeling.
Unraveling stress-adaptation pathways in cancer: Functional dissection through CRISPR-based genetic screens.
Stress dynamically modulates neuronal autophagy to gate depression onset
A zinc transporter drives glioblastoma progression via extracellular vesicles-reprogrammed microglial plasticity
Regulated cell death in cancer: Mechanisms, crosstalk, and opportunities for therapy.
A zinc transporter drives glioblastoma progression via extracellular vesicles-reprogrammed microglial plasticity.
ZEB1 promotes chemoimmunotherapy resistance in pancreatic cancer models by downregulating chromatin acetylation of CXCL16.
Selpercatinib mitigates cancer cachexia independent of anti-tumor activity in the HT1080 tumor model.
Anti-tumor effects on tumor-infiltrating natural killer cells by localized ablative immunotherapy and immune checkpoint inhibitors: An integrated and comparative study using scRNAseq analysis.
Tumor microenvironment and macroenvironment: A new perspective on holistic oncology.
Evaluation of Ferroptosis as a Biomarker to Predict Treatment Outcomes of Cancer Immunotherapy.
Publisher Correction: Stress dynamically modulates neuronal autophagy to gate depression onset
Shared HLA-Bound Neoepitopes Are New Targets for Pancreatic Cancer Immunotherapy.
Synergy between photonics and biological approaches-A review of combination therapies for cancer theranostics.
Author Correction: Stress dynamically modulates neuronal autophagy to gate depression onset
Glutaminase 2-Mediated Yes Associated Protein 1 Glutamylation Facilitates Immune Evasion in Pancreatic Ductal Adenocarcinoma.
A novel mechanism of the cachexia-promoting action of chemotherapy drugs fluorouracil and cisplatin
Supplementary Fig. S5 from Evaluation of Ferroptosis as a Biomarker to Predict Treatment Outcomes of Cancer Immunotherapy
Figure 3 from Evaluation of Ferroptosis as a Biomarker to Predict Treatment Outcomes of Cancer Immunotherapy
Supplementary Fig. S3 from Evaluation of Ferroptosis as a Biomarker to Predict Treatment Outcomes of Cancer Immunotherapy
Supplementary Fig. S4 from Evaluation of Ferroptosis as a Biomarker to Predict Treatment Outcomes of Cancer Immunotherapy
Figure 1 from Evaluation of Ferroptosis as a Biomarker to Predict Treatment Outcomes of Cancer Immunotherapy
Supplementary Fig. S1 from Evaluation of Ferroptosis as a Biomarker to Predict Treatment Outcomes of Cancer Immunotherapy
Data from Evaluation of Ferroptosis as a Biomarker to Predict Treatment Outcomes of Cancer Immunotherapy
Supplementary Table S1 from Evaluation of Ferroptosis as a Biomarker to Predict Treatment Outcomes of Cancer Immunotherapy
Supplementary Fig. S2 from Evaluation of Ferroptosis as a Biomarker to Predict Treatment Outcomes of Cancer Immunotherapy
Figure 4 from Evaluation of Ferroptosis as a Biomarker to Predict Treatment Outcomes of Cancer Immunotherapy
Supplementary Fig. S6 from Evaluation of Ferroptosis as a Biomarker to Predict Treatment Outcomes of Cancer Immunotherapy